359 related articles for article (PubMed ID: 33983968)
21. A Beneficial Role of Rooibos in Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Sasaki M; Nishida N; Shimada M
Molecules; 2018 Apr; 23(4):. PubMed ID: 29642387
[TBL] [Abstract][Full Text] [Related]
22. Aspalathin improves hyperglycemia and glucose intolerance in obese diabetic ob/ob mice.
Son MJ; Minakawa M; Miura Y; Yagasaki K
Eur J Nutr; 2013 Sep; 52(6):1607-19. PubMed ID: 23238530
[TBL] [Abstract][Full Text] [Related]
23. Anti-Diabetic Effect of a Shihunine-Rich Extract of
Li XW; Huang M; Lo K; Chen WL; He YY; Xu Y; Zheng H; Hu H; Wang J
Molecules; 2019 Jul; 24(14):. PubMed ID: 31340585
[TBL] [Abstract][Full Text] [Related]
24. The effects of a green Rooibos (
Kotzé-Hörstmann LM; Bedada DT; Johnson R; Mabasa L; Sadie-Van Gijsen H
Food Funct; 2022 Dec; 13(24):12648-12663. PubMed ID: 36441182
[TBL] [Abstract][Full Text] [Related]
25. Visualization of Aspalathin in Rooibos (
Amor Stander E; Williams W; Rautenbach F; Le Roes-Hill M; Mgwatyu Y; Marnewick J; Hesse U
Molecules; 2019 Mar; 24(5):. PubMed ID: 30866512
[TBL] [Abstract][Full Text] [Related]
26. Phenolic profiles, antihyperglycemic, antihyperlipidemic, and antioxidant properties of pomegranate (Punica granatum) peel extract.
El-Hadary AE; Ramadan MF
J Food Biochem; 2019 Apr; 43(4):e12803. PubMed ID: 31353600
[TBL] [Abstract][Full Text] [Related]
27. Aspalathin, a flavonoid in Aspalathus linearis (rooibos), is absorbed by pig intestine as a C-glycoside.
Kreuz S; Joubert E; Waldmann KH; Ternes W
Nutr Res; 2008 Oct; 28(10):690-701. PubMed ID: 19083477
[TBL] [Abstract][Full Text] [Related]
28. Enhancing aspalathin stability in rooibos (Aspalathus linearis) ready-to-drink iced teas during storage: the role of nano-emulsification and beverage ingredients, citric and ascorbic acids.
de Beer D; Joubert E; Viljoen M; Manley M
J Sci Food Agric; 2012 Jan; 92(2):274-82. PubMed ID: 21780136
[TBL] [Abstract][Full Text] [Related]
29. Differential modulatory effects of rosiglitazone and pioglitazone on white adipose tissue in db/db mice.
Yang KJ; Noh JR; Kim YH; Gang GT; Hwang JH; Yang SJ; Yeom YI; Lee CH
Life Sci; 2010 Sep; 87(13-14):405-10. PubMed ID: 20723549
[TBL] [Abstract][Full Text] [Related]
30. Combining a dipeptidyl peptidase-4 inhibitor, alogliptin, with pioglitazone improves glycaemic control, lipid profiles and beta-cell function in db/db mice.
Moritoh Y; Takeuchi K; Asakawa T; Kataoka O; Odaka H
Br J Pharmacol; 2009 Jun; 157(3):415-26. PubMed ID: 19371350
[TBL] [Abstract][Full Text] [Related]
31. Agriophyllum oligosaccharides ameliorate hepatic injury in type 2 diabetic db/db mice targeting INS-R/IRS-2/PI3K/AKT/PPAR-γ/Glut4 signal pathway.
Bao S; Wu YL; Wang X; Han S; Cho S; Ao W; Nan JX
J Ethnopharmacol; 2020 Jul; 257():112863. PubMed ID: 32302715
[TBL] [Abstract][Full Text] [Related]
32. Rauwolfia serpentina improves altered glucose and lipid homeostasis in fructose-induced type 2 diabetic mice.
Azmi MB; Qureshi SA
Pak J Pharm Sci; 2016 Sep; 29(5):1619-1624. PubMed ID: 27731821
[TBL] [Abstract][Full Text] [Related]
33. Effect of Chinese prescription Kangen-karyu on lipid metabolism in type 2 diabetic db/db mice.
Yamabe N; Kim HY; Kang KS; Zhao Q; Matsumoto K; Yokozawa T
J Ethnopharmacol; 2010 Jun; 129(3):299-305. PubMed ID: 20363309
[TBL] [Abstract][Full Text] [Related]
34. Alteration in expression profiles of a series of diabetes-related genes in db/db mice following treatment with thiazolidinediones.
Suzuki A; Yasuno T; Kojo H; Hirosumi J; Mutoh S; Notsu Y
Jpn J Pharmacol; 2000 Oct; 84(2):113-23. PubMed ID: 11128033
[TBL] [Abstract][Full Text] [Related]
35. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
[TBL] [Abstract][Full Text] [Related]
36. Hypoglycemic and hypolipidemic effects of methanol seed extract of Citrus paradisi Macfad (Rutaceae) in alloxan-induced diabetic Wistar rats.
Adeneye AA
Nig Q J Hosp Med; 2008; 18(4):211-5. PubMed ID: 19391322
[TBL] [Abstract][Full Text] [Related]
37. Model development for predicting in vitro bio-capacity of green rooibos extract based on composition for application as screening tool in quality control.
Viraragavan A; Hlengwa N; de Beer D; Riedel S; Miller N; Bowles S; Walczak B; Muller C; Joubert E
Food Funct; 2020 Apr; 11(4):3084-3094. PubMed ID: 32195502
[TBL] [Abstract][Full Text] [Related]
38. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
[TBL] [Abstract][Full Text] [Related]
39. The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice.
Shimaya A; Kurosaki E; Nakano R; Hirayama R; Shibasaki M; Shikama H
Metabolism; 2000 Mar; 49(3):411-7. PubMed ID: 10726922
[TBL] [Abstract][Full Text] [Related]
40. Effects of a fermented buckwheat flower and leaf extract on the blood glucose and lipid profile of type 2 diabetic db/db mice.
Wang J; Yu X; Jiang Y; Wang Y; Li Y; Han S
J Tradit Chin Med; 2020 Apr; 40(2):197-203. PubMed ID: 32242385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
